Risperidone versus placebo for schizophrenia
Abstract
Risperidone is the first new-generation antipsychotic drug made available in the market in its generic form.To determine the clinical effects, safety and cost-effectiveness of risperidone compared with placebo for treating schizophrenia.On 19th October 2015, we searched the Cochrane Schizophrenia Group Trials Register, which is based on regular searches of CINAHL, BIOSIS, AMED, EMBASE, PubMed, MEDLINE, PsycINFO, and registries of clinical...
Paper Details
Title
Risperidone versus placebo for schizophrenia
Published Date
Dec 15, 2016
Journal
Volume
2016
Issue
12
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History